Stage III/IV Metastatic Colorectal Cancer
Chance to Destroy "Untreatable" Colorectal Tumors
CoNexus Cancer Care Aggressively Treats Stage III/IV Colorectal Cancers:
CoNexus Cancer Care delivers concentration of approved medications directly into cancerous tumors while under CT imaging guidance. ICCA physicians have treated tens of hundreds of patients.
ICCA physicians have treated lethal Stage III/IV Metastatic Colon Cancers (colon cancer spread to liver) for over 40 years!
ICCA physicians use customized treatment plans unavailable to physicians within the U.S. or Canada – and if told chemotherapy is your only option, then get second opinion from ICCA or another cancer center ASAP!
ICCA physicians have spent years perfecting CoNexus Cancer Care; a customized, multifocal treatment approach synergistically combining:
CoNexus Cancer Care has been clinically shown to often surpass conventional cancer treatments, with fewer side-effects and far more favorable treatment outcomes!
Why, because U.S. physicians can’t or don’t use many of the cutting-edge cancer therapies or combination therein, that ICCA physicians use when treating Stage III/IV metastatic colon cancers!
Stage III/IV Metastatic Colorectal Treatment Options
Very Low-Dose Radiation with Radio-sensitizing Agent
Very low-dose radiation in combination with radio-sensitizing agent (chemo agents that selectively enhance tumor cell death during concurrent radiation yet exhibiting no toxicity on normal tissues).
Targeted low-dose radiation is often used by ICCA physicians to treat liver metastases in many colorectal patients -- with even more favorable results when a chemo-based radiation sensitizing agent is used contemporaneously.
This treatment is most often used for patients with a small number of lesions near central blood vessels in the liver. It can also be used for patients who are not candidates for or who have failed surgery or interventional radiology procedures. Image guidance is needed to accurately define and deliver radiation on daily basis (generally no more than 10 sessions total). This approach requires a special technique called gaiting where radiation is only delivered during certain parts of the respiratory cycle due to continued patient breathing.
CoNexus Cancer Care Tumor-Targeted Immunotherapy
CoNexus Cancer Care tumor-targeted immunotherapy is comprised of FDA approved compounds and substances (e.g., cytokines, haptens, etc.) that are combined, and interjected directly into the tumor tissues, eliciting an enhanced autoimmune cell response which servers to better identify evasive cancer cells and help destroy, hamper or even reverse progressive tumor growth.
Concurrent Small Dose Chemotherapy
Small volumes of systemic chemotherapy can be given concurrent with low-dose radiation, and; in certain follow-up circumstances – as a follow-up to confirm all microscopic cancer cells have been destroyed.
Select targeting agents are also available to destroy a specific growth factor or receptor lying within the tumor cells. These agents are usually given in combination with chemotherapy to help stop cancer cells from growing or spreading.
Angiogenesis inhibitors, which block formation of new blood vessels, have been approved for use against colorectal cancer spread to other parts of the body.
Vascular, Interventional Radiology & Surgical Treatment Options
Vascular, interventional radiology and surgical procedures Stage III/IV metastatic colon patients several additional treatment options.
With minimally invasive ablations can be done through open or laparoscopic approaches, or they can be performed percutaneously (through the skin). They can also be done in an effort to shrink tumors before surgery or in combination with other surgical therapies.
While every patient does not need every treatment option mentioned, having them available under "one roof" gives ICCA physicians the ability to customized each patient's treatment based on that patient’s individual needs.